Literature DB >> 21663537

Endocannabinoids and stress.

Caitlin J Riebe1, Carsten T Wotjak.   

Abstract

Endogenous cannabinoids play an important role in the physiology and behavioral expression of stress responses. Activation of the hypothalamic-pituitary-adrenal (HPA) axis, including the release of glucocorticoids, is the fundamental hormonal response to stress. Endocannabinoid (eCB) signaling serves to maintain HPA-axis homeostasis, by buffering basal activity as well as by mediating glucocorticoid fast feedback mechanisms. Following chronic stressor exposure, eCBs are also involved in physiological and behavioral habituation processes. Behavioral consequences of stress include fear and stress-induced anxiety as well as memory formation in the context of stress, involving contextual fear conditioning and inhibitory avoidance learning. Chronic stress can also lead to depression-like symptoms. Prominent in these behavioral stress responses is the interaction between eCBs and the HPA-axis. Future directions may differentiate among eCB signaling within various brain structures/neuronal subpopulations as well as between the distinct roles of the endogenous cannabinoid ligands. Investigation into the role of the eCB system in allostatic states and recovery processes may give insight into possible therapeutic manipulations of the system in treating chronic stress-related conditions in humans.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21663537     DOI: 10.3109/10253890.2011.586753

Source DB:  PubMed          Journal:  Stress        ISSN: 1025-3890            Impact factor:   3.493


  51 in total

1.  Cannabinoid receptor type 1 antagonism significantly modulates basal and loud noise induced neural and hypothalamic-pituitary-adrenal axis responses in male Sprague-Dawley rats.

Authors:  R J Newsom; C Osterlund; C V Masini; H E Day; R L Spencer; S Campeau
Journal:  Neuroscience       Date:  2011-11-28       Impact factor: 3.590

2.  Pharmacological tools to mobilise mesenchymal stromal cells into the blood promote bone formation after surgery.

Authors:  Tariq G Fellous; Andia N Redpath; Mackenzie M Fleischer; Sapan Gandhi; Samantha E Hartner; Michael D Newton; Moïra François; Suet-Ping Wong; Kate H C Gowers; Adam M Fahs; Daniel R Possley; Dominique Bonnet; Paula Urquhart; Anna Nicolaou; Kevin C Baker; Sara M Rankin
Journal:  NPJ Regen Med       Date:  2020-02-21

3.  Are the persistent effects of "gate control" stimulation on nociception a form of generalization of habituation that is endocannabinoid-dependent?

Authors:  Alex Hanson; Brian D Burrell
Journal:  Neurobiol Learn Mem       Date:  2018-09-06       Impact factor: 2.877

4.  Systems biology analysis of the endocannabinoid system reveals a scale-free network with distinct roles for anandamide and 2-arachidonoylglycerol.

Authors:  Nicola Bernabò; Barbara Barboni; Mauro Maccarrone
Journal:  OMICS       Date:  2013-10-11

Review 5.  Monoglyceride lipase as a drug target: At the crossroads of arachidonic acid metabolism and endocannabinoid signaling.

Authors:  Gernot F Grabner; Robert Zimmermann; Rudolf Schicho; Ulrike Taschler
Journal:  Pharmacol Ther       Date:  2017-02-14       Impact factor: 12.310

6.  Chronic ethanol exposure decreases CB1 receptor function at GABAergic synapses in the rat central amygdala.

Authors:  Florence P Varodayan; Neeraj Soni; Michal Bajo; George Luu; Samuel G Madamba; Paul Schweitzer; Loren H Parsons; Marisa Roberto
Journal:  Addict Biol       Date:  2015-05-05       Impact factor: 4.280

7.  Cannabinoid CB1 receptors in distinct circuits of the extended amygdala determine fear responsiveness to unpredictable threat.

Authors:  M D Lange; T Daldrup; F Remmers; H J Szkudlarek; J Lesting; S Guggenhuber; S Ruehle; K Jüngling; T Seidenbecher; B Lutz; H C Pape
Journal:  Mol Psychiatry       Date:  2016-10-04       Impact factor: 15.992

8.  Cannabinoid Receptors, Mental Pain and Suicidal Behavior: a Systematic Review.

Authors:  Laura Colino; Javier Herranz-Herrer; Elena Gil-Benito; Teresa Ponte-Lopez; Pablo Del Sol-Calderon; Maria Rodrigo-Yanguas; María Gil-Ligero; Antonio J Sánchez-López; Jose de Leon; Hilario Blasco-Fontecilla
Journal:  Curr Psychiatry Rep       Date:  2018-03-15       Impact factor: 5.285

Review 9.  Reward Processing and Risk for Depression Across Development.

Authors:  Katherine R Luking; David Pagliaccio; Joan L Luby; Deanna M Barch
Journal:  Trends Cogn Sci       Date:  2016-04-27       Impact factor: 20.229

Review 10.  Endocannabinoid signaling and synaptic function.

Authors:  Pablo E Castillo; Thomas J Younts; Andrés E Chávez; Yuki Hashimotodani
Journal:  Neuron       Date:  2012-10-04       Impact factor: 17.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.